| European Case Law Identifier: | ECLI:EP:BA:2011:T145606.20110331 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 31 March 2011 | ||||||||
| Case number: | T 1456/06 | ||||||||
| Application number: | 97307757.1 | ||||||||
| IPC class: | C12N 15/54 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Human telomerase catalytic subunit | ||||||||
| Applicant name: | Geron Corporation The Regents of the University of Colorado |
||||||||
| Opponent name: | GemVex AS | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Correction of notice of appeal (yes) Admissibility of the appeals (yes) Main request and auxiliary request 1 - added matter (yes) Auxiliary requests 2 to 4 - sufficiency of disclosure (no) Auxiliary request 5 - requirements of the EPC met (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t061456eu1.html
Date retrieved: 17 May 2021